| Name | Title | Contact Details |
|---|
Socratek is a Boston, MA-based company in the Business Services sector.
Sparx Hockey, inventors of the Sparx Skate Sharpener, is the leading developer and manufacturer of skate sharpening equipment and related accessories for ice hockey, figure skating and sled hockey. The Sparx Sharpener is an affordable, high quality automated skate sharpener that is now used by thousands of customers around the world, including individuals, families, professional and amateur teams, rink operators and retailers. Major retail customers include DICKs Sporting Goods, Canadian Tire, Scheels, and Pro Hockey Life to name a few. In addition, more than 25 National Hockey League teams are using the Sparx Sharpener and the company recently expanded its distribution to Europe and Russia. The company is focused on building a leadership position in skate sharpening by providing customers with the most advanced, accurate and easy-to-use skate sharpening equipment on the planet.
We are one of the leading suppliers of construction chemicals worldwide. At MBCC Group, we build sustainable performance in all we do.
Aaron's Bunk House Boots is a Brentwood, TN-based company in the Business Services sector.
Enavate Sciences is a life sciences investment and support platform based in California. Formed by Patient Square Capital, it focuses on fostering the growth of innovative therapeutic and enabling technology companies. With an initial capital commitment of $300 million, Enavate Sciences aims to advance the development of novel therapies, particularly in areas of unmet medical need. The company provides significant capital and strategic growth support to its portfolio companies. This includes operational experience and personalized attention to help these companies realize their full potential. Enavate Sciences invests in both pre-clinical and clinical stage companies, prioritizing those with high growth potential. Its mission is to improve patients lives by supporting innovative companies that can transform patient care through novel therapies and technologies.